Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
Clinical trial NCT05856383 · RECRUITING
Trial details
- NCT number
- NCT05856383
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-16
- Primary completion
- 2027-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.